The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Genetics of breast cancer: a topic in evolution
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B., & King, M.-C. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,550
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,924
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
A breast cancer prediction model incorporating familial and personal risk factors
Tyrer, J., Duffy, S. W., & Cuzick, J. (2004) · Statistics in Medicine · doi:10.1002/sim.1668 · Cited by 1,345
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,251
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171 · cited 1×
“Prophylactic mastectomy may also be considered due to the high lifetime cancer risk and increased risk of secondary breast cancers, with discussion of a nipple-sparing approach [3, 33, 34].”
BackgroundBasal-Like Breast Cancer: A Critical Review
Rakha, E. A., Reis-Filho, J. S., & Ellis, I. O. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1748 · Cited by 1,164
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
Cancer Incidence in BRCA1 Mutation Carriers
Thompson, D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1358 · Cited by 1,096
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
The Breast Cancer Susceptibility Collaboration (UK), Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., et al. (2007) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,003
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction
Claus, E. B., Risch, N., & Thompson, W. D. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3<643::aid-cncr2820730323>3.0.co;2-5 · Cited by 942
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
Tan, M.-H., Mester, J. L., Ngeow, J., Rybicki, L. A., Orloff, M. S., & Eng, C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2283 · Cited by 892
Lakhani, S. R., van de Vijver, M. J., Jacquemier, J., Anderson, T. J., Osin, P. P., McGuffog, L., & Easton, D. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.023 · Cited by 823
Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
Parmigiani, G., Berry, D. A., & Aguilar, O. (1998) · The American Journal of Human Genetics · doi:10.1086/301670 · Cited by 753
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09962-2 · Cited by 747
The Breast Cancer Susceptibility Collaboration (UK), Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1902 · Cited by 746 · cited 4×
“Studies have identified a number of additional DNA repair genes that interact with BRCA1, BRCA2, and/or the BRCA pathways, and confer about a twofold increase in breast cancer risk, including CHEK2 [45], BRIP1 (BACH1) [46], ATM [47], and PALB2 [48].”
BackgroundInfluentialATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
The Breast Cancer Susceptibility Collaboration (UK), Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., North, B., Jayatilake, H., Barfoot, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1837 · Cited by 743
Estimation of significance thresholds for genomewide association scans
Dudbridge, F., & Gusnanto, A. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20297 · Cited by 703
Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freedman, L., Helzlsouer, K., & Vogel, V. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1829 · Cited by 670
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
Walsh, T., Casadei, S., Coats, K. H., Swisher, E., Stray, S. M., Higgins, J., Roach, K. C., Mandell, J., Lee, M. K., Ciernikova, S., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1379 · Cited by 666
Pharoah, P. D. P., Guilford, P., & Caldas, C. (2001) · Gastroenterology · doi:10.1053/gast.2001.29611 · Cited by 638
Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk
Bloss, C. S., Schork, N. J., & Topol, E. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011893 · Cited by 562
Cancer Risks and Mortality in Heterozygous ATM Mutation Carriers
Thompson, D., Duedal, S., Kirner, J., McGuffog, L., Last, J., Reiman, A., Byrd, P., Taylor, M., & Easton, D. F. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji141 · Cited by 543
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
Antoniou, A. C., Cunningham, A. P., Peto, J., Evans, D. G., Lalloo, F., Narod, S. A., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Southey, M. C., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604305 · Cited by 525
The emerging landscape of breast cancer susceptibility
Stratton, M. R., & Rahman, N. (2008) · Nature Genetics · doi:10.1038/ng.2007.53 · Cited by 487 · cited 7×
“There is no known biallelic phenotype for CHEK2, again with the assumption that this is embryonic lethal [5].”
BackgroundInfluentialWalsh, T., Lee, M. K., Casadei, S., Thornton, A. M., Stray, S. M., Pennil, C., Nord, A. S., Mandell, J. B., Swisher, E. M., & King, M.-C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007983107 · Cited by 487
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
Birch, J. M., Alston, R. D., McNally, R. J., Evans, D. G. R., Kelsey, A. M., Harris, M., Eden, O. B., & Varley, J. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204621 · Cited by 467
Increased Risk for Cancer in Patients with the Peutz-Jeghers Syndrome
Boardman, L. A., Thibodeau, S. N., Schaid, D. J., Lindor, N. M., McDonnell, S. K., Burgart, L. J., Ahlquist, D. A., Podratz, K. C., Pittelkow, M., & Hartmann, L. C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-11-199806010-00004 · Cited by 421
Mutation of the RAD51C gene in a Fanconi anemia–like disorder
Vaz, F., Hanenberg, H., Schuster, B., Barker, K., Wiek, C., Erven, V., Neveling, K., Endt, D., Kesterton, I., Autore, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.570 · Cited by 408 · cited 1×
“It is still possible that somatic mutations within tumors, or founder effects in unique populations, are present and contribute to cancer development and progression [49, 55, 59].”
BackgroundCancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature
Liede, A., Karlan, B. Y., & Narod, S. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.055 · Cited by 407
ACR Appropriateness Criteria Breast Cancer Screening
Mainiero, M. B., Lourenco, A., Mahoney, M. C., Newell, M. S., Bailey, L., Barke, L. D., D'Orsi, C., Harvey, J. A., Hayes, M. K., Huynh, P. T., et al. (2013) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2012.09.036 · Cited by 342
Concise Handbook of Familial Cancer Susceptibility Syndromes - Second Edition
Lindor, N. M., McMaster, M. L., Lindor, C. J., & Greene, M. H. (2008) · JNCI Monographs · doi:10.1093/jncimonographs/lgn001 · Cited by 307
Models of genetic susceptibility to breast cancer
Antoniou, A. C., & Easton, D. F. (2006) · Oncogene · doi:10.1038/sj.onc.1209879 · Cited by 303
Moorman, P. G., Havrilesky, L. J., Gierisch, J. M., Coeytaux, R. R., Lowery, W. J., Peragallo Urrutia, R., Dinan, M., McBroom, A. J., Hasselblad, V., Sanders, G. D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.9021 · Cited by 303
Founder mutations in BRCA1 and BRCA2 genes
Ferla, R., Calò, V., Cascio, S., Rinaldi, G., Badalamenti, G., Carreca, I., Surmacz, E., Colucci, G., Bazan, V., & Russo, A. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm234 · Cited by 286
Follow-up study of twenty-four families with Li-Fraumeni syndrome.
Garber, J. E., Goldstein, A. M., Kantor, A. F., Dreyfus, M., Fraumeni, J. F., & Li, F. P. (1991) · PubMed · Cited by 275
Zhang, B., Beeghly-Fadiel, A., Long, J., & Zheng, W. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70076-6 · Cited by 272
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update
Gronwald, J., Tung, N., Foulkes, W. D., Offit, K., Gershoni, R., Daly, M., Kim‐Sing, C., Olsson, H., Ainsworth, P., Eisen, A., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21536 · Cited by 254
Relative frequency and morphology of cancers in STK11 mutation carriers1 ☆
Lim, W., Olschwang, S., Keller, J. J., Westerman, A. M., Menko, F. H., Boardman, L. A., Scott, R. J., Trimbath, J., Giardiello, F. M., & Gruber, S. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.014 · Cited by 254
Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?
Domchek, S. M., Bradbury, A., Garber, J. E., Offit, K., & Robson, M. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.9403 · Cited by 237
BRCA in breast cancer: ESMO Clinical Practice Guidelines
Balmaña, J., Díez, O., Rubio, I. T., & Cardoso, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr373 · Cited by 230
BRCA in breast cancer: ESMO Clinical Practice Guidelines
Balmaña, J., Diez, O., Rubio, I., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq161 · Cited by 205
Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
Eisen, A., Lubinski, J., Gronwald, J., Moller, P., Lynch, H. T., Klijn, J., Kim-Sing, C., Neuhausen, S. L., Gilbert, L., Ghadirian, P., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn313 · Cited by 194
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Phillips, K.-A., Milne, R. L., Rookus, M. A., Daly, M. B., Antoniou, A. C., Peock, S., Frost, D., Easton, D. F., Ellis, S., Friedlander, M. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.8313 · Cited by 171
Weitzel, J. N., Clague, J., Martir-Negron, A. E., Ogaz, R., Herzog, J., Ricker, C. N., Jungbluth, C. R., Cina, C., Duncan, P. R., Unzeitig, G. W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0027 · Cited by 168
Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer
Domchek, S. M., Tang, J.-B., Stopfer, J. E., Lilli, D. R., Hamel, N., Tischkowitz, M. D., Monteiro, Á. N. A., Messick, T. E., Powers, J., Yonker, A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0421 · Cited by 153
Shaag, A., Walsh, T., Renbaum, P., Kirchhoff, T., Nafa, K., Shiovitz, S., Mandell, J. B., Welcsh, P. L., Lee, M. K., Ellis, N. A., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi052 · Cited by 143
Self-citationWoodward, E. R., Sleightholme, H., Considine, A., Williamson, S., McHugo, J. M., & Crüger, D. G. (2007) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01499.x · Cited by 137
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers
Evans, D. G., Gaarenstroom, K. N., Stirling, D., Shenton, A., Mæhle, L., Dørum, A., Steel, M., Lalloo, F. I., Apold, J., Porteous, M. E., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058248 · Cited by 137
Lowry, K. P., Lee, J. M., Kong, C. Y., McMahon, P. M., Gilmore, M. E., Chubiz, J. E. C., Pisano, E. D., Gatsonis, C. A., Ryan, P. D., Ozanne, E. M., et al. (2011) · Cancer · doi:10.1002/cncr.26424 · Cited by 134
Validating and Improving Models for Projecting the Absolute Risk of Breast Cancer
Gail, M. H., & Costantino, J. P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.5.334 · Cited by 124
Palma, M. D., Domchek, S. M., Stopfer, J. E., Erlichman, J., Siegfried, J. D., Tigges-Cardwell, J., Mason, B. A., Rebbeck, T. R., & Nathanson, K. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0599 · Cited by 107
Thompson, B. A., Greenblatt, M. S., Vallee, M. P., Herkert, J. C., Tessereau, C., Young, E. L., Adzhubey, I. A., Li, B., Bell, R., Feng, B., et al. (2013) · Human Mutation · doi:10.1002/humu.22214 · Cited by 95
Prophylactic and Therapeutic Mastectomy in BRCA Mutation Carriers: Can the Nipple Be Preserved?
Reynolds, C. A., Davidson, J. A., Lindor, N. M., Glazebrook, K. N., Jakub, J. W., Degnim, A. C., Sandhu, N. P., Walsh, M. F., Hartmann, L. C., & Boughey, J. C. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1908-8 · Cited by 82
Vézina, H., Durocher, F., Dumont, M., Houde, L., Szabo, C., Tranchant, M., Chiquette, J., Plante, M., Laframboise, R., Lépine, J., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-1297-9 · Cited by 58
Rapakko, K., Allinen, M., Syrjäkoski, K., Vahteristo, P., Huusko, P., Vähäkangas, K., Eerola, H., Kainu, T., Kallioniemi, O., Nevanlinna, H. A., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1530 · Cited by 58
PALB2 analysis in BRCA2-like families
Adank, M. A., van Mil, S. E., Gille, J. J. P., Waisfisz, Q., & Meijers-Heijboer, H. E. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1001-1 · Cited by 53
Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families
Teo, Z. L., Park, D. J., Provenzano, E., Chatfield, C., Odefrey, F., Nguyen‐Dumont, T., kConFab, Dowty, J. G., Hopper, J. L., Winship, I., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3392 · Cited by 49
Desjardins, S., Beauparlant, J. C., Labrie, Y., Ouellette, G., BRCAs, I., & Durocher, F. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-181 · Cited by 40
Calvez‐Kelm, F. L., Oliver, J., Damiola, F., Forey, N., Robinot, N. R., Durand, G., Voegele, C., Vallée, M., Byrnes, G. B., Breast Cancer Family Registry, et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052374 · Cited by 39
Leeneer, K. D., Bockstal, M. V., Brouwer, S. D., Swietek, N., Schietecatte, P., Sabbaghian, N., den Ende, J. V., Willocx, S., Storm, K., Blaumeiser, B., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1998-4 · Cited by 27
Rouleau, É., Jesson, B., Briaux, A., Noguès, C., Chabaud, V., Demange, L., Sokolowska, J., Coulet, F., Barouk-Simonet, E., Bignon, Y., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2009-5 · Cited by 24
He, M. Y., Di, G., Cao, A., Hu, Z., Jin, W., Shen, Z., & Shao, Z. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1700-2 · Cited by 22
Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis
Pabalan, N., Jarjanazi, H., & Özçelik, H. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2364-2 · Cited by 19
Haanpää, M. K., Pylkäs, K., Moilanen, J. S., & Winqvist, R. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-82 · Cited by 17
Lee, C. H. (2013) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2013.01.034 · Cited by 16
Clinical characteristics of breast cancer in patients with an NBS1 mutation
Huzarski, T., Cybulski, C., Jakubowska, A., Byrski, T., Gronwald, J., Domagała, P., Szwiec, M., Godlewski, D. D., Kilar, E., Marczyk, E., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2692-x · Cited by 6
Personal Genomic Testing as Part of the Complete Breast Cancer Risk Assessment: A Case Report
Riordan, S., Rodriguez, D. F., & Kieran, S. M. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9506-x · Cited by 4
Cited by
Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021) · Cancers · doi:10.3390/cancers13174287 · Cited by 1,960
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0003 · Cited by 650
[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D., Zaguia, A., Koundal, S., & Belay, A. (2022) · BioMed Research International · doi:10.1155/2022/9605439 · Cited by 529
RetractedAlmansour, N. M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.836417 · Cited by 397
Metadata
- Authors
- Shiovitz, S., & Korde, L. A.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 26
- Issue
- 7
- Pages
- 1291-1299
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2125171234
- Cited by
- 525
- References
- 76
- FWCI
- 19.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.